MetLife Director Adds to Stake via 562-Share Compensation Grant

Rhea-AI Filing Summary

MetLife, Inc. (MET) – Form 4 insider transaction

Director Carla A. Harris disclosed the acquisition of 562 MetLife common shares on 17 Jun 2025. The reference price reported was $77.85, implying a transaction value of roughly $43.7 thousand. The shares stem from the company’s normal non-management director compensation program and were deferred through the MetLife Deferred Compensation Plan for Non-Management Directors. Post-transaction ownership equals 8,484 directly held shares. No derivative positions were created or exercised, and no shares were sold. The filing appears routine and compensation-related, with limited impact on overall share float or corporate governance.

Insights

Financial Analyst

TL;DR: Small, routine director stock grant; immaterial to MET valuation or trading outlook.

The Form 4 shows a standard equity retainer paid in stock, not an open-market purchase. At under $45k, the grant is negligible versus MetLife’s multi-billion-dollar market cap and does not alter insider ownership materially. No signal regarding management’s view on valuation can be inferred, and no derivative activity was reported. Investors can consider the filing neutral for earnings, cash-flow, or capital-return expectations.

Corporate Governance Expert

TL;DR: Routine compensation equity grant; maintains director–shareholder alignment, no red flags.

Using stock to pay a portion of director fees is a common governance practice that modestly aligns board interests with shareholders. The deferred receipt under the Director Deferred Compensation Plan further links the director’s long-term incentives to company performance. However, the small size means the alignment effect is minimal, and the filing raises neither governance concerns nor positive surprises. Overall governance impact: neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harris Carla A

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A(1)		562	A	$77.85	8,484	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Morgan Mayes, Authorized Signer	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Carla A. Harris report for MET?

An acquisition of 562 shares of MetLife common stock as part of director compensation.

When did the MET insider acquisition occur?

The transaction date was June 17, 2025.

What was the reported price per share for the acquisition?

The reference price disclosed in the Form 4 was $77.85 per share.

How many MetLife shares does Carla A. Harris own after the transaction?

Her direct beneficial ownership increased to 8,484 shares.

Was the transaction an open-market purchase?

No. It was a routine director retainer paid in stock and deferred under the company’s compensation plan.